Hyponatremia – Frequency, Causes, Pathobiochemistry, Clinics and Therapy.
Authors:
A. Kazda
Authors place of work:
Ústav lékařské biochemie a laboratorní diagnostiky 1. LF UK a VFN, Praha
Published in the journal:
Klin. Biochem. Metab., 26, 2018, No. 4, p. 157-165
Summary
Objective:
Presentation of the current knowledge of hyponatremias in terms of their causes, frequency and pathobiochemical connections in development and treatment of these disbalances
Study type:
Synoptic
Settings:
Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine and General University Hospital, Prague
Material and Methods: Based on the study of global literature is in the survey the frequency and prognostic importance of hyponatremia evaluated. Its hypotonic and non-hypotonic forms are described as well as pathophysiological consequences for the brain and clinical signs. The therapeutic proceedings are mentioned together with accompanying risks. It is referred about the problems of hyponatremia in neurointensive care, in older age and in the relation to the health of bones.
Results:
The frequency of hyponatremia in three large sets of patients admitted to ICU of various specialisations was between 10.0 % till 17.1 %. Its value is given by decreased relation of sodium supply in extracellular fluid (ECF) and size of ECF. Hyponatremia causes the decrease of osmolality – hypotonic form. If there are contemporary present another osmotically effective solutes in ECF (glucose, mannitol) they cause the shift of water from the cells to the ECF and natremia is diluted – non-hypotonic form. Decreased osmolality of ECF accompanying hyponatremia leads to the shift of water to the cells. The brain is therefore swelling and hyponatraemic encephalopathy develops. The clinical signs and prognostic significance of this evolution are described in relation to the categorization of natrium decrease. Brain compensates this disturbance by decreasing the content of ions and small organic molecules in its cells. Therapeutic proceedings are described. The rate of correction has to respect the time, necessary for the restoration if eliminated osmotically active particles back in brain cells. Maximal elevation of hyponatremia is 10 mmol/l/day and in risk patients yet less. More rapid correction is risk for brain demyelinisation. Differential diagnosis and treatment of hyponatremia is described in neurointensive care. It is referred about increased frequency of hyponatremia and its consequences in elder age and about its relation to bone fracture and osteoporosis.
Conclusion:
Hyponatremia is connected with more severe pathobiochemical changes and accompanied by elevated morbidity and mortality.
Keywords:
hyponatremia, encephalopathy, body fluids, cerebral salt-wasting syndrome, syndrome of inappropriate antidiuretic hormone secretion.
Zdroje
1. Funk, G. Ch., Lindner, G., Druml, W. et al. Incidence of dysnatremias in critical care. Int. Care Med., 2010, 36, p. 304-311.
2. Sakr, Y., Rother, S., Ferreira, A. M. P. et al. Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients. Crit Care Med, 2013, 41, p. 133-142.
3. Arampatzis, S., Frauchiger, B., Fiedler, G. M. et al. Characteristics, symptoms, and outcome of severe dysnatremias present on hospital admission. Amer. J. Med., 2012, 125, 11, 1125e1-1125e7.
4. Wiliams, D. M., Gallagher, M., Handley, J. et al. The clinical management of hyponatraemia. Postgrad. Med. J., 2016, 92, p. 407-411.
5. Buffington, M. A., Abreo, K. Hyponatremia: a review. J. Intens. Care Med., 2016, 31(4), p. 223-236.
6. Sterns, R. H., Silver, S. M. Complications and management of hyponatremia. Curr. Opin. Nephrol. Hypertens, 2016, 25, p. 114-119.
7. Jabor, A., Franeková, J. Hyponatrémie. Labor Aktuell, 2014, 3, p. 13-15.
8. Liamis, G., Milionis, H., Elisaf, M. A review of drug-induced hyponatremia. Am. J. Kidney Diseas., 2008, 52, 1, p. 144-153.
9. Jabor, A. et al. Vnitřní prostředí. Praha, Grada, Publishing 2008, 312 s. ISBN 978-80-247-1221-5.
10. Weismann, D., Schneider, A., Höybye, Ch. Clinical aspects of symptomatic hyponatremia. Endocr. Connections, 2016, 5, R35-R43.
11. Filippatos, T. D., Elisaf, M. S., Liamis, G. Hyponatremia in the elderly: challenges and solutions. Devepress, 2017, 12, p. 1957-1965.
12. Heinrich, S., Wagner, S., Gross, P. Hyponaträmie. Med. Clin. Intensive Med. Notfmed., 2012, 108, p. 53-58.
13. Brodská, H., Kazda, A., Křemen, J. Komplexní kazuistika – diabetické koma. In Průša, R. Kazuistiky a stručné kapitoly z klinické biochemie. Praha: ÚKBP, 2. LF UK Praha a FN Motol 2009, s. 124-127.
14. Spasovski, G., Vanholder, R., Allolio, B. et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Int. Care Med., 2014, 40, p. 320-331.
15. Kengne, F., G., Decaux, G. Hyponatremia and the brain. Kidney Internat. Reports., 2018, 3, p. 24-35.
16. Negri, A. L., Ayus, J. C. Hyponatremia and bone disease. Rev. Endocr. Metab. Disord., 2004, 18, p. 67-78.
17. Rondon-Berrios, H., Berl, T. Vasopresin receptor antagonists in hyponatremia: uses and misuses. Front. Med., 2017, 4, art. 141.
18. Dasta, J., Waikar, S. S., Xie, L. et al. Patterns of treatment and correction of hyponatremia in intensive care unit patients. J. Crit. Care, 2015, 30, p. 1072-1079.
19. Špatenková, V., Škrabálek, P. Protokol diagnostiky a léčby hyponatremie a hypernatremie v neurointenzivní péči. Cesk. Slov. Neurol., 2015, 78/111(1), s. 34-37.
20. Berardi, R., Rinaldi, S., Caramanti, M. et al. Hyponatremia in cancer patients: time for a new approach. Crit. Rev. Oncology/Hematology, 2016, 102, p. 15-25.
21. Shah, M. K., Mandayam, S., Adrogue, H. J. Osmotic demyelination unrelated to hyponatremia. Am. J. Kidney Dis., 2017, 71(3), p. 436-440.
22. Khan, M. I., Dellinger, R. P., Vaguespack, S. G. Electrolyte disturbances in critically ill cancer patients: an endocrine perspective. J. Intens. Care Med., 2018, 33, p. 147-158.
23. Hall, A., O´Kane, R. The extracranial consequences of subarachnoid hemorrhage. World Neurosurg., 2018, 109, p. 381-392.
24. Lolin, Y., Jackowski, A. Hyponatremia in neurosurgical patients. Br. J. Neurosurg., 1992, 6, p. 457-466.
25. Špaténková, V., Kazda, A., Barsa, P. et al. Diagnostika hyponatremií v neurointenzivní péči: úloha renálních funkčních parametrů. Cesk. Slov. Neurol. N., 2008, 71/104(2), p. 156-162.
26. Coussement, J., Danguy, Ch., Zouaoui-Boudjeltia, K. et al. Treatment of the syndrome of inappropriate secretion of antidiuretik hormone with urea in critically ill patients. Am. J. Nephrol., 2012, 35, p. 265-270.
27. Kraft, M. D., Btaiche, I. F., Sacks, G. S. Treatment of electrolyte disorders in adult patients in the intensive care unit. Amer. J. Health Syst. Pharm., 2005, 62, p. 1663-1682.
28. Fibbi, B., Benvenuti, S., Giuliani, C. et al. Low extracellular sodium promotes adipogenic commitment of human mesenchymal stromal cells: a novel mechanism for chronic hyponatremia-induced bone loss. Endocrine, 2016, 52, p. 73-85.
29. Holm, J. P., Amar, A. O. S., Hyldstrup, L., Jensen, J. E. B. , a risk factor for osteoporosis and fractures in women. Osteopor. Int., 2016, 27, p. 989-1001.
30. Kazda, A. et al. Kritické stavy. Praha, Galén, 2012, 346 s. ISBN 978-80-7262-763-9.
Štítky
Clinical biochemistry Nuclear medicine Nutritive therapistČlánok vyšiel v časopise
Clinical Biochemistry and Metabolism
2018 Číslo 4
Najčítanejšie v tomto čísle
- Hyponatremia – Frequency, Causes, Pathobiochemistry, Clinics and Therapy.
- Hemolysis index as a tool for determination of free hemoglobin in plasma.
- Zeman M.: Refeeding syndrome after paleodiet
- Kidney stones - effect of indapamide treatment – a case study